James B. Weissman
Net Worth

Last updated:

What is James B. Weissman net worth?

The estimated net worth of Mr. James B. Weissman is at least $9,974,644 as of 15 Dec 2021. He owns shares worth $611,520 as insider, has earned $1,577,884 from insider trading and has received compensation worth at least $7,785,240 in Dicerna Pharmaceuticals, Inc..

What is the salary of James B. Weissman?

Mr. James B. Weissman salary is $648,770 per year as Executive Vice President & Chief Operating Officer in Dicerna Pharmaceuticals, Inc..

How old is James B. Weissman?

Mr. James B. Weissman is 63 years old, born in 1962.

What stocks does James B. Weissman currently own?

As insider, Mr. James B. Weissman owns shares in one company:

Company Title Shares Price per share Total value
Dicerna Pharmaceuticals, Inc. (DRNA) Executive Vice President & Chief Operating Officer 16,000 $38.22 $611,520

What does Dicerna Pharmaceuticals, Inc. do?

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercializing of ribonucleic acid interference (RNAi)-based pharmaceuticals. The company develops pharmaceuticals using its GalXC RNAi platform for the treatment of diseases involving the liver, including rare, cardiometabolic, viral, and chronic liver diseases; complement-mediated diseases; and neurodegenerative diseases and pain. Its principal development programs include nedosiran for the treatment of primary hyperoxaluria; RG6346 for the treatment of chronic hepatitis B virus infection; belcesiran for the treatment of deficiency-associated liver disease; and DCR-AUD for the treatment of alcohol use disorder. Dicerna Pharmaceuticals, Inc. has strategic collaborations with Novo Nordisk A/S, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc., Eli Lilly and Company, Alnylam Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., and Boehringer Ingelheim International GmbH. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts. As of December 27, 2021, Dicerna Pharmaceuticals, Inc. operates as a subsidiary of Novo Nordisk A/S.

DRNA logo
DRNA
Dicerna Pharmaceuticals, Inc.
$38.22

James B. Weissman insider trading

Dicerna Pharmaceuticals, Inc.

Mr. James B. Weissman has made 27 insider trades between 2013-2021, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 30,000 units of DRNA stock on 6 Jul 2021. As of 15 Dec 2021 he still owns at least 16,000 units of DRNA stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 3,775 N/A N/A
Option
Restricted Stock Units 3,775 N/A N/A
Option
Common Stock 30,000 $9.09 $272,700
Sale
Common Stock 30,000 $9.09 $272,700
Option
Employee Stock Option (Right to Buy) 30,000 $9.09 $272,700
Sale
Common Stock 4,904 N/A N/A
Sale
Common Stock 7,156 N/A N/A
Sale
Common Stock 5,808 $24.08 $139,868
Sale
Common Stock 3,800 N/A N/A
Option
Restricted Stock Units 8,650 N/A N/A
Option
Common Stock 8,650 $24.05 $208,033
Option
Employee Stock Option (Right to Buy) 4,360 N/A N/A
Sale
Common Stock 4,360 $3.42 $14,911
Option
Common Stock 4,360 N/A N/A
Sale
Common Stock 4,360 $3.42 $14,911
Option
Common Stock 4,360 $3.42 $14,911
Option
Employee Stock Option (Right to Buy) 4,360 $3.42 $14,911
Option
Employee Stock Option (Right to Buy) 10,000 $2.97 $29,700
Option
Common Stock 10,000 N/A N/A
Option
Employee Stock Option (Right to Buy) 8,720 $3.42 $29,822
Sale
Common Stock 8,720 $3.42 $29,822
Option
Common Stock 8,720 $3.42 $29,822
Sale
Common Stock 4,360 $22.56 $98,344
Option
Common Stock 4,360 $3.2 $13,930
Option
Employee Stock Option (Right to Buy) 4,360 $3.2 $13,930
Option
Employee Stock Option (Right to Buy) 4,360 $2.97 $12,949
Sale
Common Stock 4,360 $26.63 $116,098
Option
Common Stock 4,360 $2.97 $12,949
Sale
Common Stock 4,360 $2.97 $12,949
Option
Employee Stock Option (Right to Buy) 4,360 $2.97 $12,949
Option
Common Stock 4,360 $2.97 $12,949
Sale
Common Stock 4,360 $2.97 $12,949
Option
Common Stock 4,360 $2.97 $12,949
Option
Employee Stock Option (Right to Buy) 4,360 $2.97 $12,949
Option
Common Stock 4,360 $2.97 $12,949
Sale
Common Stock 4,360 $2.97 $12,949
Option
Employee Stock Option (Right to Buy) 4,360 $2.97 $12,949
Option
Common Stock 4,360 $2.97 $12,949
Sale
Common Stock 4,360 $2.97 $12,949
Option
Employee Stock Option (Right to Buy) 4,360 $2.97 $12,949
Option
Common Stock 4,360 $2.97 $12,949
Option
Employee Stock Option (Right to Buy) 4,360 $2.97 $12,949
Sale
Common Stock 4,360 $2.97 $12,949
Sale
Common Stock 4,360 $21.88 $95,375
Option
Employee Stock Option (Right to Buy) 4,360 $3.2 $13,930
Option
Common Stock 4,360 $3.2 $13,930
Option
Common Stock 11,001 $9.09 $99,999
Option
Employee Stock Option (Right to Buy) 11,001 $9.09 $99,999
Sale
Common Stock 20,000 $2.97 $59,400
Option
Common Stock 20,000 $2.97 $59,400
Option
Employee Stock Option (Right to Buy) 20,000 $2.97 $59,400
Sale
Common Stock 20,000 $3.42 $68,400
Option
Common Stock 20,000 $3.42 $68,400
Option
Employee Stock Option (Right to Buy) 20,000 $3.42 $68,400
Sale
Common Stock 20,000 $3.42 $68,400
Option
Common Stock 20,000 $3.42 $68,400
Option
Employee Stock Option (Right to Buy) 20,000 $3.42 $68,400
Option
Employee Stock Option (Right to Buy) 20,000 $3.42 $68,400
Option
Common Stock 20,000 $3.42 $68,400
Sale
Common Stock 20,000 $3.42 $68,400
Option
Common Stock 15,000 $3.42 $51,300
Sale
Common Stock 15,000 $3.42 $51,300
Option
Employee Stock Option (Right to Buy) 15,000 $3.42 $51,300
Option
Employee Stock Option (Right to Buy) 4,904 $3.42 $16,772
Option
Common Stock 4,904 $3.42 $16,772
Sale
Common Stock 14,680 $13.07 $191,838
Sale
Common Stock 15,000 $3.42 $51,300
Option
Employee Stock Option (Right to Buy) 15,000 $3.42 $51,300
Option
Common Stock 15,000 $3.42 $51,300
Option
Common Stock 2,301 $3.42 $7,869
Option
Employee Stock Option (Right to Buy) 2,301 $3.42 $7,869
Sale
Common Stock 2,301 $3.42 $7,869
Option
Common Stock 14,680 $3.42 $50,206
Option
Employee Stock Option (Right to Buy) 14,680 $3.42 $50,206
Option
Employee Stock Option (Right to Buy) 10,000 $3.42 $34,200
Option
Common Stock 10,000 $3.42 $34,200
Sale
Common Stock 10,000 $3.42 $34,200
Sale
Common Stock 8,965 $13 $116,545
Sale
Common Stock 1,035 $13 $13,455
Purchase
Common Stock 5,000 $3.27 $16,365
Purchase
Common Stock 1,000 $15 $15,000
Option
Common Stock 11,283 $3.24 $36,557
Option
Employee Stock Option (right to buy) 11,283 $1.71 $19,294
Option
Employee Stock Option (right to buy) 833 N/A N/A
Option
Common Stock 833 $3.42 $2,849

Dicerna Pharmaceuticals key executives

Dicerna Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: